Semantic Scholar Open Access 2020 1543 sitasi

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

M. Pollán B. Pérez-Gómez Roberto Pastor-Barriuso J. Oteo Miguel A. Hernán +105 lainnya

Abstrak

Background Spain is one of the European countries most affected by the COVID-19 pandemic. Serological surveys are a valuable tool to assess the extent of the epidemic, given the existence of asymptomatic cases and little access to diagnostic tests. This nationwide population-based study aims to estimate the seroprevalence of SARS-CoV-2 infection in Spain at national and regional level. Methods 35 883 households were selected from municipal rolls using two-stage random sampling stratified by province and municipality size, with all residents invited to participate. From April 27 to May 11, 2020, 61 075 participants (75·1% of all contacted individuals within selected households) answered a questionnaire on history of symptoms compatible with COVID-19 and risk factors, received a point-of-care antibody test, and, if agreed, donated a blood sample for additional testing with a chemiluminescent microparticle immunoassay. Prevalences of IgG antibodies were adjusted using sampling weights and post-stratification to allow for differences in non-response rates based on age group, sex, and census-tract income. Using results for both tests, we calculated a seroprevalence range maximising either specificity (positive for both tests) or sensitivity (positive for either test). Findings Seroprevalence was 5·0% (95% CI 4·7–5·4) by the point-of-care test and 4·6% (4·3–5·0) by immunoassay, with a specificity–sensitivity range of 3·7% (3·3–4·0; both tests positive) to 6·2% (5·8–6·6; either test positive), with no differences by sex and lower seroprevalence in children younger than 10 years (10%) and lower in coastal areas (<3%). Seroprevalence among 195 participants with positive PCR more than 14 days before the study visit ranged from 87·6% (81·1–92·1; both tests positive) to 91·8% (86·3–95·3; either test positive). In 7273 individuals with anosmia or at least three symptoms, seroprevalence ranged from 15·3% (13·8–16·8) to 19·3% (17·7–21·0). Around a third of seropositive participants were asymptomatic, ranging from 21·9% (19·1–24·9) to 35·8% (33·1–38·5). Only 19·5% (16·3–23·2) of symptomatic participants who were seropositive by both the point-of-care test and immunoassay reported a previous PCR test. Interpretation The majority of the Spanish population is seronegative to SARS-CoV-2 infection, even in hotspot areas. Most PCR-confirmed cases have detectable antibodies, but a substantial proportion of people with symptoms compatible with COVID-19 did not have a PCR test and at least a third of infections determined by serology were asymptomatic. These results emphasise the need for maintaining public health measures to avoid a new epidemic wave. Funding Spanish Ministry of Health, Institute of Health Carlos III, and Spanish National Health System.

Topik & Kata Kunci

Penulis (110)

M

M. Pollán

B

B. Pérez-Gómez

R

Roberto Pastor-Barriuso

J

J. Oteo

M

Miguel A. Hernán

M

M. Pérez-Olmeda

J

J. L. Sanmartín

A

Aurora Fernández-García

I

Israel Cruz

N

N. Fernández de Larrea

M

Marta Molina

F

F. Rodríguez-Cabrera

M

M. Martín

P

P. Merino-Amador

J

José León Paniagua

J

Juan F. Muñoz-Montalvo

F

Faustino Blanco

R

R. Yotti

F

Faustino Rodrigo Mariano Saturnino Marta Juan F. Matías Jos Blanco Gutiérrez Fernández Martín Mezcua Navarro M

F

Faustino Blanco

R

Rodrigo Gutiérrez Fernández

M

M. Martín

S

Saturnino Mezcua Navarro

M

Marta Molina

J

Juan F. Muñoz-Montalvo

M

Matías Salinero Hernández

J

J. L. Sanmartín

M

M. Cuenca‐Estrella

R

R. Yotti

J

José León Paniagua

N

N. Fernández de Larrea

P

P. Fernández-Navarro

R

Roberto Pastor-Barriuso

B

B. Pérez-Gómez

M

M. Pollán

A

A. Avellón

G

G. Fedele

A

Aurora Fernández-García

J

Jesus Oteo Iglesias

M

M. T. Pérez Olmeda

I

Israel Cruz

M

M. E. Fernandez Martinez

F

F. Rodríguez-Cabrera

M

Miguel A. Hernán

S

S. Padrones Fernández

J

J. Rumbao Aguirre

J

J. M. Navarro Mari

B

B. Palop Borrás

A

A. P. Pérez Jiménez

M

M. Rodríguez-Iglesias

A

A. C. Calvo Gascón

M

M. L. Lou Alcaine

I

I. Donate Suárez

Ó

Óscar Suárez Álvarez

M

M. Rodríguez Pérez

M

Margarita Cases Sanchís

C

C. J. Villafáfila Gomila

L

L. Carbo Saladrigas

A

A. Hurtado Fernández

A

A. Oliver

E

Elías Castro Feliciano

M

M. N. González Quintana

J

J. M. Barrasa Fernández

M

M. A. Hernández Betancor

M

M. Hernández Febles

L

L. Martín Martín

L

L. López López

T

Teresa Ugarte Miota

I

Inés De Benito Población

M

M. S. Celada Pérez

M

M. N. Vallés Fernández

T

Tomás Maté Enríquez

M

Miguel Villa Arranz

M

Marta Domínguez-Gil González

I

I. Fernández-Natal

G

Gregoria Megías Lobón

J

J. L. Muñoz Bellido

P

P. Ciruela

A

Ariadna Mas i Casals

M

Maria Doladé Botías

M

M. Á. Marcos Maeso

D

D. Pérez Del Campo

A

Antonio Félix de Castro

R

Ramón Limón Ramírez

M

M. F. Elías Retamosa

M

M. Rubio González

M

M. S. Blanco Lobeiras

A

Alberto Fuentes Losada

A

A. Aguilera

G

G. Bou

Y

Yolanda Caro

N

Noemí Marauri

L

L. M. Soria Blanco

I

I. del Cura González

M

M. Hernández Pascual

R

R. Alonso Fernández

P

P. Merino-Amador

N

N. Cabrera Castro

A

Aurora Tomás Lizcano

C

Cristóbal Ramírez Almagro

M

M. Segovia Hernández

N

N. Ascunce Elizaga

M

M. Ederra Sanz

C

Carmen Ezpeleta Baquedano

A

Ana Bustinduy Bascaran

S

Susana Iglesias Tamayo

L

Luis Elorduy Otazua

R

Rebeca Benarroch Benarroch

J

Jesús Lopera Flores

A

A. Vázquez de la Villa

Format Sitasi

Pollán, M., Pérez-Gómez, B., Pastor-Barriuso, R., Oteo, J., Hernán, M.A., Pérez-Olmeda, M. et al. (2020). Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. https://doi.org/10.1016/S0140-6736(20)31483-5

Akses Cepat

Informasi Jurnal
Tahun Terbit
2020
Bahasa
en
Total Sitasi
1543×
Sumber Database
Semantic Scholar
DOI
10.1016/S0140-6736(20)31483-5
Akses
Open Access ✓